martes, 24 de marzo de 2020

Why does pharma still make drugs using a slow, batch-based process?

Why does pharma still make drugs using a slow, batch-based process?

Cancer Briefing

STAT Plus: Despite investments and advocacy, pharma’s still making its drugs in batches that can take months — rather than continuously. Why?

By NICHOLAS FLORKO


ADOBE
There’s a way to cut weeks, if not months, off of the time it takes to produce medicines. So why hasn’t pharma bought in?

No hay comentarios:

Publicar un comentario